Truist cuts Greif stock price target to $78 on lowered guidance

Greif cut the low end of its fiscal 2026 EBITDA guidance to $610 million from $630 million after a $5 million hit from Middle East conflict, but maintained $315 million in free cash flow guidance. Fiscal Q2 Class A operating EPS was $1.10 versus Truist's $1.13 estimate and the company also reported a wider earnings miss in recent results, with EPS of $0.68 versus $1.11 expected and revenue of $1.07 billion versus $1.11 billion consensus. Offset to the weaker outlook, Greif completed its $150 million buyback and has a further $300 million authorization, while leverage remains low at about 1.1x versus a 2.0x target.

Analysis

GEF reads less like a clean quality compounder and more like a capital-allocation story with an earnings cushion. The combination of sub-2x leverage, ongoing buybacks, and a stable dividend means management can keep engineering per-share metrics even if end-market demand stays sluggish; that tends to support the stock in a choppy tape, but it also caps multiple expansion because the market will continue to discount cyclical volatility and limited organic growth.

The bigger second-order issue is that the guidance cut tied to geopolitics is less about one quarter’s noise and more about the fragility of cost pass-through in a weak demand environment. If input inflation persists while volumes remain soft, Greif’s ability to protect margins depends on pricing discipline across packaging markets where competitors may be more aggressive on share capture. That creates a subtle risk of margin erosion over the next 2-3 quarters even if reported EPS looks fine on a buyback-adjusted basis.

The market is likely underappreciating how much of the “cheap” valuation is already explained by cyclicality and execution risk. A low multiple plus strong capital returns can be a value trap if EBITDA is plateauing and the company is forced to choose between M&A, buybacks, and dividend support; with leverage this low, any misstep in deployment could compress the equity story from “cash return” to “stagnant industrial.” The contrarian angle is that the stock may be more interesting on weakness if the market overreacts to the guidance trim, but not yet compelling as a momentum long until there is evidence that volumes stabilize and pricing offsets cost pressure for at least one more quarter.

Key Decisions for Investors

• Avoid initiating a fresh outright long in GEF here; the risk/reward is only attractive on a further pullback because the current setup is already pricing in low growth and execution uncertainty.
• If long, use a 3-6 month horizon and structure it as a covered-call or call spread rather than stock; the thesis is capital-return support plus downside protection, not a rerating story.
• Consider a pair trade: long a higher-quality packaging peer with more visible volume/pricing power, short GEF, to isolate execution and capital-allocation dispersion over the next 1-2 quarters.
• Watch for a catalyst in the next earnings cycle: if management confirms pricing is offsetting inflation and preserves FCF guidance, the stock can rerate 10-15%; if not, downside toward the mid-$50s is plausible as the market de-risks the dividend/buyback support case.
• If using options, prefer short-dated put spreads into any post-earnings strength; implied volatility should be monetizable because the core story is range-bound rather than trending.